Q stock Traders

[I Like Bottom Fishing]

Allyaustin if you have time please take a look at OSCIQ and see if you find any information from the bankruptcy courts, on OSCIQ this one may have a big bottom reversal run coming into it, Here is another good example of a beat down drug biopharmaceutical company stock that was taken down by the MM's and almost the same stock pattern and only to rebound strong once the MM's let it go back up on a strong reversal chart pattern. I think there is a strong monetary reason why the MM's are playing games with this stock OSCIQ!!! This is only my hypothesis scenario analysis. Perhaps there was something miss in a previous press release that we miss, Do your own dd research and see what you come up with there could be very big money involve here, maybe OSCIQ will reveal more to you or perhaps wou may have better luck getting information out of them. When OSCIQ does a bottom reversal to go back up trend mode it may go back up with some very nice gains the way the MM's are trying to flush out everyone, imo, jmho!

Drug and bio pharmaceutical stock have been very hot lately!!!

CTIC and VRMLQ from pennies to dollars USD!!!

Why the MM's manipulation of OSCIQ pps ???

God bless and always the best of trading.

CONTACT: Steven M. Rauscher (CEO)

Oscient Pharmaceuticals Corporation
1000 Winter Street
Suite 2200
Waltham, MA 02451
P: [phone]
P: [phone] / [phone]
F: [phone]

http://finance.yahoo.com/q/pr?s=CTIC

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=ctic#getCompanyInfo

http://www.knobias.com/individual/public/quote.htm?ticker=CTIC

http://www.knobias.com/individual/public/quote.htm?ticker=VRMLQ

http://www.knobias.com/individual/public/quote.htm?ticker=OSCIQ

http://www.knobias.com/individual/public/quote.htm?ticker=CTIC











http://www.knobias.com/individual/public/quote.htm?ticker=VRMLQ

http://www.knobias.com/individual/public/quote.htm?ticker=VRMLQ

http://www.knobias.com/individual/public/quote.htm?ticker=VRMLQ












http://www.knobias.com/individual/public/quote.htm?ticker=VRMLQ

http://www.knobias.com/individual/public/quote.htm?ticker=OSCIQ

http://www.knobias.com/individual/public/quote.htm?ticker=CTIC

Oscient Pharmaceuticals Corporation (pinksheets: OSCIQ) Stock Symbol:Company Profile:
http://www.knobias.com/individual/public/quote.htm?ticker=OSCIQ
Knobias MEMBERS get: Quotes | Charts | Technical Analysis | Quick Profiles | EDGAR Filings | News & Alerts | TearSheet Profiles | Historical Statistics | Insider Transactions | Institutional Holdings | ...and Much More
http://www.knobias.com/individual/public/quote.htm?ticker=OSCIQ

Last Trade: 0.031 Change: 0.001 ( +3.333 %)
Previous Close: 0.030 Today's Open: 0.029
# of Trades: 26 Volume: 681,604
Avg. # of Trades: 43 Avg. Daily Volume: 623,910

Bid: N/A Bid Size: N/A
Ask: N/A Ask Size: N/A
Day High: 0.032 Day Low: 0.027
52 Week High: 0.529 52 Week Low: 0.016
Market Cap: 1.21M Dividend: N/A
EPS: N/A P/E Ratio: N/A

6 Month Chart

RAiDAR alerts Learn More About RAiDAR-LT
09/29/2009 (23:42 ET) India's Lupin buys US rights for cholesterol drug Antara - AsiaPulse Pte. Ltd. - Asia In Focus
09/29/2009 (22:58 ET) INDIA'S LUPIN BUYS US MKT RIGHTS OF ANTARA DRUG FOR US$38.61 MLN - AsiaPulse Pte. Ltd
09/09/2009 (07:10 ET) Cornerstone Wins Factive Rights - Zacks.com
09/05/2009 (13:07 ET) Cornerstone wins approval to acquire rights to Oscient's antibiotic drug - Datamonitor
09/03/2009 (08:01 ET) Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R) - PR Newswire
08/10/2009 (09:50 ET) OSCIQ: New 52-Wk Low @ $0.020 dn 20% - Knobias
08/07/2009 (12:40 ET) OSCIQ: New 52-Wk Low @ $0.025 dn 9.26% - Knobias
08/06/2009 (15:10 ET) OSCIQ: New 52-Wk Low @ $0.026 dn 13.33% - Knobias
07/31/2009 (12:00 ET) OSCIQ: New 52-Wk Low @ $0.028 dn 12.5% - Knobias
07/30/2009 (10:10 ET) OSCIQ: New 52-Wk Low @ $0.029 dn 6.35% - Knobias
07/28/2009 (09:55 ET) OSCIQ: Filed New Form 25-NSE - Edgar
07/22/2009 (03:12 ET) The MedZilla Report: June 2009 Employment Outlook for Biotech/Pharma/Health - PRWeb.com
07/20/2009 (11:40 ET) OSCI: Volume Spike; 43% > 20-adsv, Stock +53.25% - Knobias
07/20/2009 (10:10 ET) OSCI: New 52-Wk Low @ $0.035 dn 9.09% - Knobias
07/17/2009 (12:10 ET) OSCI: New 52-Wk Low @ $0.041 dn 16.12% - Knobias
07/17/2009 (08:20 ET) AnalystChoice.com Brings You the Best Complimentary Research Report on DLTR, PMCS, CMCSA, DDUP, CREE and OSCI - Market Wire
07/15/2009 (08:51 ET) Oscient Pharmaceuticals files for Chapter 11 bankruptcy protection - Datamonitor
07/15/2009 (07:10 ET) Cornerstone Buys OSCI Antibiotic - Zacks.com
07/14/2009 (23:07 ET) Oscient Pharmaceuticals Files for Chapter 11 Relief - Close-Up Media
07/14/2009 (13:16 ET) Cornerstone Therapeutics signs asset purchase agreement with Oscient - Datamonitor
07/14/2009 (07:40 ET) Cornerstone Therapeutics To Buy Factive Rights - Investrend
07/13/2009 (17:51 ET) OSCI: Files Chapter 11; To Sale Assets of FACTIVE to Cornerstone Therapeutics - Knobias
07/13/2009 (17:35 ET) Cornerstone Therapeutics Signs Definitive Asset Purchase Agreement to Acquire Commercial Rights to the Antibiotic Factive(R) - PR Newswire
07/13/2009 (17:12 ET) OSCI: Filed New Form 8-K, Material Event Disclosure - Edgar

company profile
A commercial-stage pharmaceutical company, which markets products to primary care physicians, cardiologists, endocrinologists and pulmonologists in the United States. ... MORE INFO

CONTACT: Steven M. Rauscher (CEO)
Oscient Pharmaceuticals Corporation
1000 Winter Street
Suite 2200
Waltham, MA 02451
P: [phone]
P: [phone] / [phone]
F: [phone]
Company Home Page | Email

Industry: Drugs
SIC: 2834
Employees: 316
Locations: 0

State of Inc: MASSACHUSETTS
Development Stage? N Transfer Agent:
Computershare Investor Services
Golden, CO 80401

Investor Relations:
Company Authorized Shares: 174,375,000
Source: 10-Q ( 09/30/2006 )

Outstanding Shares: 39,003,978
Source: MGFS ( 03/20/2009 )

Fiscal Year End: December 31

MANAGEMENT & INSIDERS:

Need More Stock Research? Subscribe NOW!!!

http://www.knobias.com/individual/public/quote.htm?ticker=OSCIQ

ABOUT | PARTNERS | ADVERTISING INFO | CONTACT US | COPYRIGHT | PRIVACY | LEGAL | DISCLAIMER
Copyright © 2009 Knobias.Com, LLC. All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Knobias.Com, LLC, nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Knobias.Com website(s), a user agrees not to redistribute the information found therein. Knobias.Com, LLC is not a registered broker-dealer and does not endorse or recommend any securities listed herein or any services of any brokerage company.